The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study
Open accessAbstract
Importance: Approximately 20% of fine-needle aspirations (FNA) of thyroid nodules have indeterminate cytology, most frequently Bethesda category III or IV. Diagnostic surgeries can be avoided for these patients if the nodules are reliably diagnosed as benign without surgery. Objective: To determine the diagnostic accuracy of a multigene classifier (GC) test (ThyroSeq v3) for cytologically indeterminate thyroid nodules. Design, Setting, and Participants: Prospective, blinded cohort study conducted at 10 medical centers, with 782 patients with 1013 nodules enrolled. Eligibility criteria were met in 256 patients with 286 nodules; central pathology review was performed on 274 nodules. Interventions: A total of 286 FNA samples from thyroid nodules underwent molecular analysis using the multigene GC (ThyroSeq v3). Main Outcomes and Measures: The primary outcome was diagnostic accuracy of the test for thyroid nodules with Bethesda III and IV cytology. The secondary outcome was prediction of cancer by specific genetic alterations in Bethesda III to V nodules. Results: Of the 286 cytologically indeterminate nodules, 206 (72%) were benign, 69 (24%) malignant, and 11 (4%) noninvasive follicular thyroid neoplasms with papillary-like nuclei (NIFTP). A total of 257 (90%) nodules (154 Bethesda III, 93 Bethesda IV, and 10 Bethesda V) had informative GC analysis, with 61% classified as negative and 39% as positive. In Bethesda III and IV nodules combined, the test demonstrated a 94% (95% CI, 86%-98%) sensitivity and 82% (95% CI, 75%-87%) specificity. With a cancer/NIFTP prevalence of 28%, the negative predictive value (NPV) was 97% (95% CI, 93%-99%) and the positive predictive value (PPV) was 66% (95% CI, 56%-75%). The observed 3% false-negative rate was similar to that of benign cytology, and the missed cancers were all low-risk tumors. Among nodules testing positive, specific groups of genetic alterations had cancer probabilities varying from 59% to 100%. Conclusions and Relevance: In this prospective, blinded, multicenter study, the multigene GC test demonstrated a high sensitivity/NPV and reasonably high specificity/PPV, which may obviate diagnostic surgery in up to 61% of patients with Bethesda III to IV indeterminate nodules, and up to 82% of all benign nodules with indeterminate cytology. Information on specific genetic alterations obtained from FNA may help inform individualized treatment of patients with a positive test result.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationApproximate is Better than “Exact” for Interval Estimation of Binomial Proportions
Agresti, A., & Coull, B. A. (1998) · The American Statistician · doi:10.1080/00031305.1998.10480550 · Cited by 3,223
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
Tessler, F. N., Middleton, W. D., Grant, E. G., Hoang, J. K., Berland, L. L., Teefey, S. A., Cronan, J. J., Beland, M. D., Desser, T. S., Frates, M. C., et al. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.01.046 · Cited by 2,530
The 2017 Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2017) · Thyroid · doi:10.1089/thy.2017.0500 · Cited by 1,844
Management of a Solitary Thyroid Nodule
Desforges, J. F., & Mazzaferri, E. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280807 · Cited by 1,412
Nikiforov, Y. E., Seethala, R. R., Tallini, G., Baloch, Z. W., Basolo, F., Thompson, L. D. R., Barletta, J. A., Wenig, B. M., Al Ghuzlan, A., Kakudo, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0386 · Cited by 1,404
Self-citationRuss, G., Bonnema, S. J., Erdogan, M. F., Durante, C., Ngu, R., & Leenhardt, L. (2017) · European Thyroid Journal · doi:10.1159/000478927 · Cited by 1,284
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Alexander, E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., Friedman, L., Kloos, R. T., LiVolsi, V. A., Mandel, S. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203208 · Cited by 1,163
Self-citationWorldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604412 · Cited by 1,145
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedüs, L., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,088
Self-citationThe Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L., & Baloch, Z. W. (2012) · Acta Cytologica · doi:10.1159/000339959 · Cited by 1,032
Self-citationVery high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination
Guth, S., Theune, U., Aberle, J., Galach, A., & Bamberger, C. M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02162.x · Cited by 978
Baloch, Z. W., LiVolsi, V. A., Asa, S. L., Rosai, J., Merino, M. J., Randolph, G., Vielh, P., DeMay, R. M., Sidawy, M. K., & Frable, W. J. (2008) · Diagnostic Cytopathology · doi:10.1002/dc.20830 · Cited by 880
Self-citationThe Diagnosis and Management of Thyroid Nodules: A Review
Durante, C., Grani, G., Lamartina, L., Filetti, S., Mandel, S. J., & Cooper, D. S. (2018) · JAMA · doi:10.1001/jama.2018.0898 · Cited by 803
Self-citationMolecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
Nikiforov, Y. E., Steward, D. L., Robinson-Smith, T. M., Haugen, B. R., Klopper, J. P., Zhu, Z., Fagin, J. A., Falciglia, M., Weber, K., & Nikiforova, M. N. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0247 · Cited by 711
Self-citationNikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., Hodak, S. P., LeBeau, S. O., Ohori, N. P., et al. (2014) · Cancer · doi:10.1002/cncr.29038 · Cited by 500
Self-citationTargeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
Nikiforova, M. N., Wald, A. I., Roy, S., Durso, M. B., & Nikiforov, Y. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2292 · Cited by 485
Self-citationNatural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
Tuttle, R. M., Fagin, J. A., Minkowitz, G., Wong, R. J., Roman, B., Patel, S., Untch, B., Ganly, I., Shaha, A. R., Shah, J. P., et al. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.1442 · Cited by 484
TERT promoter mutations in thyroid cancer
Liu, R., & Xing, M. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0533 · Cited by 441
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules
Nikiforova, M. N., Mercurio, S., Wald, A. I., Barbi de Moura, M., Callenberg, K., Santana‐Santos, L., Gooding, W. E., Yip, L., Ferris, R. L., & Nikiforov, Y. E. (2018) · Cancer · doi:10.1002/cncr.31245 · Cited by 396
Self-citationNikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., LeBeau, S. O., Ohori, N. P., Seethala, R. R., et al. (2015) · Thyroid · doi:10.1089/thy.2015.0305 · Cited by 394
Self-citationPatel, K. N., Angell, T. E., Babiarz, J., Barth, N. M., Blevins, T., Duh, Q.-Y., Ghossein, R. A., Harrell, R. M., Huang, J., Kennedy, G. C., et al. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1153 · Cited by 393
Self-citationHaugen, B. R., Sawka, A. M., Alexander, E. K., Bible, K. C., Caturegli, P., Doherty, G. M., Mandel, S. J., Morris, J. C., Nassar, A., Pacini, F., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0628 · Cited by 339
Self-citationCantara, S., Capezzone, M., Marchisotta, S., Capuano, S., Busonero, G., Toti, P., Di Santo, A., Caruso, G., Carli, A. F., Brilli, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2103 · Cited by 315
Liu, R., Bishop, J., Zhu, G., Zhang, T., Ladenson, P. W., & Xing, M. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3288 · Cited by 296
Labourier, E., Shifrin, A., Busseniers, A. E., Lupo, M. A., Manganelli, M. L., Andruss, B., Wylie, D., & Beaudenon-Huibregtse, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1158 · Cited by 279
Sosa, J. A., Hanna, J. W., Robinson, K. A., & Lanman, R. B. (2013) · Surgery · doi:10.1016/j.surg.2013.07.006 · Cited by 248
Self-citationA Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Cibas, E. S., Baloch, Z. W., Fellegara, G., LiVolsi, V. A., Raab, S. S., Rosai, J., Diggans, J., Friedman, L., Kennedy, G. C., Kloos, R. T., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00006 · Cited by 215
Self-citationHarrell, R. M., & Bimston, D. N. (2013) · Endocrine Practice · doi:10.4158/ep13330.or · Cited by 149
Tumor Genotype Determines Phenotype and Disease-related Outcomes in Thyroid Cancer
Yip, L., Nikiforova, M. N., Yoo, J. Y., McCoy, K. L., Stang, M. T., Armstrong, M. J., Nicholson, K. J., Ohori, N. P., Coyne, C. J., Hodak, S. P., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001420 · Cited by 138
Self-citationLithwick‐Yanai, G., Dromi, N., Shtabsky, A., Morgenstern, S., Strenov, Y., Feinmesser, M., Kravtsov, V., Leon, M. E., Hajdúch, M., Ali, S. Z., et al. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204089 · Cited by 126
Brauner, E., Holmes, B., Krane, J. F., Nishino, M., Zurakowski, D., Hennessey, J. V., Faquin, W. C., & Parangi, S. (2015) · Thyroid · doi:10.1089/thy.2015.0049 · Cited by 123
Baloch, Z. W., Seethala, R. R., Faquin, W. C., Papotti, M. G., Basolo, F., Fadda, G., Randolph, G. W., Hodak, S. P., Nikiforov, Y. E., & Mandel, S. J. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21744 · Cited by 120
Self-citationHaser, G. C., Tuttle, R. M., Su, H. K., Alon, E. E., Bergman, D. A., Bernet, V. J., Brett, E. M., Cobin, R. H., Dewey, E. H., Doherty, G. M., et al. (2016) · Endocrine Practice · doi:10.4158/ep151065.ra · Cited by 82
Decaussin‐Petrucci, M., Descôtes, F., Depaepe, L., Lapras, V., Denier, M. ‐., Borson‐Chazot, F., Lifante, J. C., & Lopez, J. (2017) · Cytopathology · doi:10.1111/cyt.12493 · Cited by 70
Molecular profiling of thyroid nodule fine-needle aspiration cytology
Eszlinger, M., Lau, L. W., Ghaznavi, S. A., Symonds, C. J., Chandarana, S. P., Khalil, M., & Paschke, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.24 · Cited by 69
Evidence-based laboratory medicine - a guide for critical evaluation of in vitro laboratory testing
Christenson, R. H. (2007) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456307780118127 · Cited by 55
Melo, M., da Rocha, A. G., Vinagre, J., Sobrinho-Simões, M. A., & Soares, P. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4614 · Cited by 41
Dunea, G. (2006) · Diagnostic Cytopathology · doi:10.1002/(issn)1097-0339 · Cited by 41
Cited by
Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00020-x · Cited by 590
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Self-citationUpdate on Fundamental Mechanisms of Thyroid Cancer
Prete, A., Borges de Souza, P., Censi, S., Muzza, M., Nucci, N., & Sponziello, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00102 · Cited by 471
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management
Durante, C., Hegedüs, L., Czarniecka, A., Paschke, R., Russ, G., Schmitt, F., Soares, P., Solymosi, T., & Papini, E. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0067 · Cited by 425
Contemporary Thyroid Nodule Evaluation and Management
Grani, G., Sponziello, M., Pecce, V., Ramundo, V., & Durante, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa322 · Cited by 317
Metadata
- Authors
- Steward, D. L., Carty, S. E., Sippel, R. S., Yang, S. P., Sosa, J. A., Sipos, J. A., Figge, J. J., Mandel, S., Haugen, B. R., Burman, K. D., Baloch, Z. W., Lloyd, R. V., Seethala, R. R., Gooding, W. E., Chiosea, S. I., Gomes-Lima, C., Ferris, R. L., Folek, J. M., Khawaja, R. A., Kundra, P., Loh, K. S., Marshall, C. B., Mayson, S., McCoy, K. L., Nga, M. E., Ngiam, K. Y., Nikiforova, M. N., Poehls, J. L., Ringel, M. D., Yang, H., Yip, L., & Nikiforov, Y. E.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-02-01
- Volume
- 5
- Issue
- 2
- Pages
- 204
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2900078105
- Cited by
- 486
- References
- 40
- FWCI
- 29.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.